MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes remained nearly identical when patients used its MiniMed 780G automated insulin ...
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced results from a new randomized crossover study demonstrating that glycemic outcomes for study participants were virtually ...
New analyses examine Afrezza across pediatric A1c and efficacy, patient treatment satisfaction, use with AID algorithms and ...
Ralinepag works by restoring prostacyclin signaling and activating prostacyclin receptors to affect pathways that play a role in the progression of PAH. The drug was originally formulated as an ...
Read more about Age-friendly healthcare needs better digital design as older adults face usability gaps on Devdiscourse ...
Morning Overview on MSN
Hospitals are now letting AI read mammograms first — and a major study found it caught 20% more cancers than doctors working alone
When a woman walks into a breast cancer screening clinic in Sweden or Germany today, her mammogram may be scored by an ...
The Vigilant AI Monitoring Operations System (VAMOS) was developed at Vanderbilt to monitor AI performance in real-time; now ...
Evan is a Communications student based in Edmonton, Alberta. Formerly a sports writer, he was drawn to Game Rant by his longtime passion for video games. An avid gamer since the age of 13, Evan has ...
In insulin-naïve Japanese patients, once-weekly efsitora was as effective and safe as once-daily degludec in lowering HbA1c, ...
CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of ...
The interventions can safely and effectively reduce antibiotic use among patients with ARIs in village clinics in rural China. Future implementation efforts should further examine the barriers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results